- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 31/00 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patent holdings for IPC class A61P 31/00
Total number of patents in this class: 6540
10-year publication summary
|
187
|
171
|
278
|
369
|
319
|
418
|
406
|
405
|
333
|
197
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Mondobiotech Laboratories AG | 311 |
275 |
| Bristol-myers Squibb Company | 4855 |
65 |
| The Regents of the University of California | 20087 |
42 |
| Merck Patent GmbH | 5768 |
30 |
| Centre National de La Recherche Scientifique | 10531 |
30 |
| Agency for Science, Technology and Research | 3646 |
26 |
| The General Hospital Corporation | 4771 |
23 |
| Novartis AG | 10725 |
22 |
| The Johns Hopkins University | 5714 |
22 |
| F. Hoffmann-La Roche AG | 7947 |
21 |
| President and Fellows of Harvard College | 5998 |
21 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3364 |
21 |
| Boehringer Ingelheim International GmbH | 4646 |
20 |
| Takeda Pharmaceutical Company Limited | 2706 |
20 |
| The University of North Carolina at Chapel Hill | 2053 |
20 |
| Pfizer Inc. | 3375 |
19 |
| Incyte Corporation | 1024 |
19 |
| Merck Sharp & Dohme Corp. | 2191 |
18 |
| AstraZeneca AB | 2895 |
18 |
| Daiichi Sankyo Company, Limited | 1886 |
17 |
| Other owners | 5791 |